S. Ayari

发表

Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity

P. Chevallier, M. Mohty, P. Moreau, 2012, Bone Marrow Transplantation.

Escalated lymphodepletion Followed by Donor Lymphocyte Infusion (DLI) can Induce a Graft-Versus-Host Response without Overwhelming Toxicity.

P. Chevallier, M. Mohty, P. Moreau, 2009 .

Re-administration of a combination of chemotherapy + Gemtuzumab at relapse in CD33+ AML patient allows to second remission and is feasible without extra toxicity.

P. Chevallier, C. Touzeau, J. Delaunay, 2008, Leukemia research.

Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.

M. Labopin, P. Chevallier, M. Mohty, 2014, Experimental hematology.

Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation

P. Chevallier, M. Mohty, P. Moreau, 2012, Bone Marrow Transplantation.

Is ASCT With TBI Superior to ASCT Without TBI in Mantle Cell Lymphoma Patients?

P. Chevallier, M. Mohty, P. Moreau, 2012, Transplantation.

Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases

A. Stamatoullas, P. Fenaux, L. Adès, 2009, Leukemia.

Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation

P. Chevallier, M. Mohty, P. Moreau, 2011, Leukemia.

Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.

P. Chevallier, M. Mohty, P. Moreau, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases

P. Chevallier, M. Mohty, H. Avet-Loiseau, 2009, Leukemia.

Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation

P. Chevallier, M. Mohty, M. Béné, 2015, Annals of Hematology.

Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced‐intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo‐SCT)

P. Chevallier, M. Mohty, P. Moreau, 2013, European journal of haematology.

Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot series.

P. Chevallier, M. Mohty, E. Lippert, 2012, Leukemia research.

[Cutaneous, mucosal and systemic pyoderma gangrenosum].

S. Barbarot, J. Stalder, C. Durant, 2010, Annales de dermatologie et de venereologie.

Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies.

P. Chevallier, M. Mohty, P. Moreau, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-lasting HHV-6 reactivation in long-term adult survivors after double umbilical cord blood allogeneic stem cell transplantation.

P. Chevallier, M. Mohty, M. Rimbert, 2014, The Journal of infectious diseases.

Herpes simplex meningitis after surgical removal of a clivus chordoma

B. Lina, M. Aymard, D. Thouvenot, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Cidofovir for recurrent respiratory papillomatosis ( RRP ) : A re-assessment of risks

R. Nicollas, J. Bour, M. Gagnieu, 2005 .

Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors

P. Chevallier, M. Mohty, P. Moreau, 2009, Bone Marrow Transplantation.

Plasmodium falciparum causing hemophagocytic syndrome after allogeneic blood stem cell transplantation.

T. Ben Othman, A. Abdelkefi, L. Torjman, 2004, The hematology journal : the official journal of the European Haematology Association.

Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.

P. Chevallier, M. Mohty, P. Moreau, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors

P. Chevallier, M. Mohty, P. Moreau, 2010, Bone Marrow Transplantation.

Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens

D. Blaise, M. Mohty, P. Moreau, 2008, Bone Marrow Transplantation.

Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT

P. Chevallier, M. Mohty, P. Moreau, 2014, Bone Marrow Transplantation.

Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma

P. Chevallier, M. Mohty, P. Moreau, 2010, Leukemia & lymphoma.

Persistence of CD33 expression at relapse in CD33+ acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease

P. Chevallier, M. Mohty, H. Avet-Loiseau, 2008, British journal of haematology.